NCT01524848 Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib Status COMPLETED Phase PHASE2
NCT01483014 Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST) Status COMPLETED Phase PHASE2
NCT01478373 Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib Status COMPLETED Phase PHASE2
NCT01462994 Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST) Status COMPLETED Phase PHASE3
NCT01440959 Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST): TKI258 Status COMPLETED Phase PHASE2
NCT01421680 The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients Status COMPLETED Phase NA
NCT01396148 A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor Status COMPLETED Phase PHASE2
NCT01381822 Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors Status UNKNOWN Phase PHASE1
NCT01289028 Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib. Status COMPLETED Phase PHASE3
NCT01275222 Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT01271712 Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST) Status COMPLETED Phase PHASE3
NCT01270984 Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01265979 WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib Status COMPLETED Phase N/A
NCT01172548 Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST) Status COMPLETED Phase PHASE2
NCT01151852 Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT Status COMPLETED Phase PHASE3
NCT01114087 Impact of the Inhibitors of Tyrosine Kinase on the Male Fertility Status COMPLETED Phase NA
NCT01031628 Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients Status TERMINATED Phase PHASE3